Femoral Fractures
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Peptide
1100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Radius HealthAbaloparatide
PfizerTranexamic Acid plus standard of care
Innovation PharmaceuticalsDensiProbe Hip
Clinical Trials (3)
Total enrollment: 280 patients across 3 trials
Supracondylar Distal Femur Fractures and Abaloparatide
Start: Jun 2024Est. completion: Jun 20250
Phase 4Withdrawn
Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture
Start: Apr 2009Est. completion: Jun 201082 patients
Phase 4Completed
Influence of Bone Strength Measured by DensiProbe on Bone Related Fixation Failure
Start: Nov 2008Est. completion: Sep 2011198 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.